In the skin, cytotoxic CD8+ T cells and Th1-skewed responses-occasionally with contributions from Th17 pathways—have been implicated in targeting antigens shared between tumor cells and keratinocytes or melanocytes, producing lichenoid interface injury or vitiligo-like depigmentation. This evidence concerns the gene CD8A and neoplasm.